J = 7.1 Hz, H6), 3.70 (ddd, J1 = 2.6 Hz, J2 = 4.5 Hz, J3 = 11.8 Hz,
H3), 3.47 (m, 2H, H1b and H5), 2.22 (qd, 1H, J1 ≈ J2 ≈ J3 ≈
12 Hz, J4 = 4,8 Hz, H2a), 1.88 (ddd, J1 = 1.6 Hz, J2 = 4.3 Hz,
J3 = 12.5 Hz, H2b). 13C NMR (92 MHz, CDCl3): d (ppm) (158.7,
158.6) C2py, (149.1, 149.0) C6py, (137.2, 136.7) C4py, (122.8, 122.5,
122.3, 121.2) (C3py, C5py), 79.5 C3, 78.6 C5, 75.8 C4, (75.0, 71.3)
CH2C2py, 66.2 C1, 60.4 C6, 27.2 C2. MS-ES: 331.2 (4%) [M + H];
353.2 (100%) [M + Na].
(OCH2py), 40.0 (C5), {26.7 and 26.2 (MeIp)}. MS-ES: 281.2 (5%)
[M + H] ; 303.1 (100%) [M + Na].
5-(Amino-N-(2-salicyl))-5-deoxy-1,2-O-isopropylidene-3-O-(2-
picolyl)-a-D-xylofuranose (L3). G (500 mg, 1,78 mmol, 1 eq.) was
dissolved in 15 mL absolute ethanol. Salicylaldehyde (217 mg,
1.78 mmol, 1 eq.) was added, which caused the immediate appear-
ance of a yellow colour. The solution was cooled (water-ice bath),
NaBH4 (67 mg, 1.77 mmol, 1 eq.) was added inducing the disap-
pearance of the yellow coloration. The reaction mixture was stirred
more than 30 minutes at RT. Excess NaBH4 was destroyed with
acetic acid. The solvent was evaporated and L3 was purified by
chromatography (AcOEt–MeOH/NH3, v/v/v = 95/5/2). Yield:
420 mg (61%). Microanalysis (calc./found) C21H26N2O5·0.4H2O :
C 64.07/64.12, H 6.86/6.81, N 7.12/6.35%. 1H NMR (300 MHz,
CDCl3): d (ppm, see Scheme 5) 8.30 (1H, d, J = 4.3 Hz, H6py),
7.61 (1H, td, J1 = 7.7 Hz, J2 = 1.6 Hz, H4py), 7.24 (1H, d, J =
7.7 Hz, H3py), {7.12 (m, 2H), 6.96 (d, 1H, J = 6.6 Hz), 6.77 (m,
2H), (HPhOH s, H5py)}, 5.92 (d, 1H, J = 3.8 Hz, H1), {4.76 and 4.58
(2 × d, 2 × 1H, J = 13.4 Hz, OCH2py)}, 4.65 (d, 1H, J = 3.8 Hz,
H2), 4.37 (td, J1 = 7.0 Hz, J2 = 3.3 Hz, H4), {4.05 and 3,92 (2 ×
d, 2 × 1H, J = 13.9 Hz, NHCH2PhOH}, 3.9 (d, J = 3.3 Hz, H3),
5-Azido-5-deoxy-1,2-O-isopropylidene-3-O-(2-picolyl)-a-D-xylo-
furanose (F). 5-Azido-5-deoxy-1,2-O-isopropylidene-a-D-xylo-
furanose (E) was synthesized as previously published.17 The
condition 2 were applied. E (1.29 g, 6 mmol) was picolylated
in toluene/(NaOHaq 50%) (14/10 mL) using 2-picolyl chloride
hydrochloride (1.48 g, 9 mmol, 1.5 eq./E), 0.2 mL of tert-amyl
alcohol, and NBu4HSO4 (0.19 g, 0.6 mmol, 0.1 eq.). After
treatment (see above), F was purified by chromatography
(SiO2, from CH2Cl2 to CH2Cl2–MeOH, 9 : 1). Yield: 1.22 g
(66%). Microanalysis: calc./found for C14H18N4O4·1/3H2O: C
54.10/54.06, H 6.00/5.78, N 17.94/17.69%. 1H NMR (250 MHz,
CDCl3): d (ppm, see Scheme 5) 8.53 (d, 1H, J = 4.8 Hz, H6py),
7.69 (td, 1H, J1 = 7.7 Hz, J2 = 1.6 Hz, H4py), 7.37 (d, 1H, J =
7.7 Hz, H3py), 7.19 (m, 1H, H5py), 5.92 (d, 1H, J = 3.7 Hz, H1),
{4.78, (d, 1H, J = 12,9 Hz), 4,65 (m, 2H) OCH2py, H2}, 4.32 (m,
1H, H4), 4.02 (d, J = 3.1 Hz, H3), 3.57 (m, 2H, H5a and H5b),
{1.48 and 1.30 (2 × s, 2 × 3H, MeiP)}. 13C NMR (62.5 MHz,
CDCl3): d (ppm) 157.3 (C2py), 149.2 (C6py), 136.8 (C4py), {122.8,
121.5} (C3py, C5py), 111.9 (CquatIp), 105.1 (C1), {82.2, 81.2} (C2,
C4), 78.6 (C3), 72.6 (OCH2py), 49.2 (C5), {26.8, 26.2} (MeIp).
MS-ES: 329.1 (100%) [M + Na].
2.98 (m, 2H, H5a, H5b), {1.47 and 1.30 (2 × s, 2 × 3H, MeIp)}. 13
C
NMR (75 MHz, CDCl3): d (ppm) {158.2 and 157.1 (C1PhOH and
C2py)}, 149.1 (C6py), 136.8 (C4py), {128.7, 128.5, 122.8, and 121.6
(C3py, C5py, C3PhOH, C5PhOH)}, 126.1 (C2PhOH), {119.0 and 116.3,
(C6PhOH, C4PhOH)}, 111.7 (CquatiP), 104.9 (C1), {82.4 and 82.1 (C2,
C4)}, 78.8 (C3), 71.8 (OCH2Py), 52.6 (NHCH2PhOH), 48.6 (C5),
{26.7 and 26.2 (MeIp)}. MS-ES: 409.2 (100%) [M + Na].
5-Azido-5-deoxy-1,2-O-isopropylidene-3-O-(N-methylimidazol-
2-yl)-a-D-xylofuranose (H). H was synthesized using the same
protocol as F using 2-imidazolyl chloride hydrochloride42 instead
of 2-picolyl chloride hydrochloride and E. E (1.84 g, 8.55 mmol)
was imidazolated in toluene/(NaOHaq 50%) (14/10 mL) using 2-
imidazolyl chloride hydrochloride (1.71 g, 10.26 mmol, 1.2 eq./
E), 0.35 mL of tert-amyl alcohol and NBu4HSO4 (0.28 g,
0.85 mmol, 0.1 eq.). After treatment (see above), H was purified
by chromatography (SiO2, elution gradient: AcOEt to AcOEt–
MeOH 95 : 5). Yield: 1.50 g (57%). 1H NMR (250 MHz, CDCl3):
d (ppm, see Scheme 6) 6.73 (1H, d, J = 6.9 Hz, H3Im), 6.70 (1H, d,
J = 6.9 Hz, H4Im), 5.64 (1H, d, J = 3.6 Hz, H1), {4.49 (d, 1H, J =
12.4 Hz), 4.46 (m, 2H) (OCH2Im, H2)}, 4.33 (m, 1H, H4), 4.06 (d,
J = 2.9 Hz, H3), 3.46 (s, 3H, MeIm), 3.26 (dd, J1 = 12.0 Hz, J2 =
7.4 Hz, H5a), 3.11 (dd, J1 = 12.0 Hz, J2 = 4.8 Hz, H5b), {1.25
and 1.08 (2 × s, 2 × 3H, MeiP)}. 13C NMR (90 MHz, CDCl3):
d (ppm) 143.4 (C2Im), 127.5 (C3Im), 122.2, (C4Im), 111.7 (Cquat iP),
104.8 (C1), {(81.6, 81.1, 78.3) (C2, C3, C4)}, 63.2 (OCH2Im), 48.9
(C5), 32.6 (MeIm), (26.5, 26.0) (OCMe2).
Scheme 5 Proton assignments.
5-Amino-5-deoxy-1,2-O-isopropylidene-3-O-(2-picolyl)-a-D-xylo-
furanose (G). F (1 g, 3 mmol) was dissolved in MeOH (10 mL)
and hydrogenated under pressure (P(H2) = 5 bar) using Pd/C as a
catalyst. After 3 h, the catalyst was removed by filtration on Celite
which was washed with MeOH. The solvent was evaporated and G
was obtained quantitatively as an oil. Microanalysis: calc./found
for C14H20N2O4·2/3H2O:
C
57.52/58.04,
H
7.36/7.05,
N
5-Amino-5-deoxy-1,2-O-isopropylidene-3-O-(N-methylimidazol-
2-yl)-a-D-xylofuranose (I). I was synthesized quantitatively
using the same protocol as G. H (0.88 g, 2.84 mmol) was
dissolved in MeOH (10 mL) and hydrogenated under pressure
(P(H2) = 5 bar) using Pd/C as a catalyst. After one night, the
catalyst was removed by filtration on Celite which was washed
with MeOH. The solvent was evaporated and I was obtained
quantitatively as an oil. 1H NMR (250 MHz, CDCl3): d (ppm, see
Scheme 6) 6.83 (1H, d, J = 7.0 Hz, H3Im), 6.78 (1H, d, J = 7.1 Hz,
H4Im), 5.85 (1H, d, J = 3.8 Hz, H1), {4.62 (d, 1H, J = 12.6 Hz),
9.12/9.85%. 1H NMR (250 MHz, CDCl3): d (ppm, see Scheme 5)
8.51 (m, 1H, H6py), 7.65 (td, 1H, J1 = 7.7 Hz, J2 = 1.7 Hz, H4py),
7.31 (d, 1H, J = 7.7 Hz, H3py), 7.18 (m, 1H, H5py), 5.90 (d, 1H,
J = 3.7 Hz, H1), {4.77 and 4.59 (2 × d, 2 × 1H, J = 13.3 Hz,
OCH2py)}, 4.63 (d, J = 3.7 Hz, H2), 4.24 (m, 1H, H4); 4,00 (d,
J = 3.2 Hz, H3), 3.07 (m, 2H, H5a and H5b), {1.44 and 1.26 (2 ×
s, 2 × 3H, MeiP)}. 13C NMR (62.5 MHz, CDCl3): d (ppm) 157.0
(C2py), 149.0 (C6py), 137.1 (C4py), {122.9, 121.5} (C3py, C5py),
111.7 (CquatIp), 104.9 (C1), {82.8, 82.1} (C2, C4), 80.3 (C3), 72.0
This journal is
The Royal Society of Chemistry 2008
Dalton Trans., 2008, 3235–3245 | 3243
©